A Single-Dose, Randomized, Placebo- and Active-Control, Four-Way, Cross-Over Study for the Evaluation of the Effect of Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) on the QT/QTc Intervals in Adult Healthy Subjects
Clinical trial NCT04238195 · COMPLETED
Trial details
- NCT number
- NCT04238195
- Sponsor
- Spero Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-19
- Primary completion
- 2020-02-26
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.